February 24, 2023

APC Fellow nominations are OPEN

Designation as an APC Fellow is the highest distinction awarded by APC, and the nomination process for 2023 is now open.

February 24, 2023

HHS projects October 2023 MOU release

HHS has released its plan of work for the coming year, including a proposed release date for the latest iteration of the MOU on interstate shipments of compounded medications.

February 24, 2023

EduCon continues…

For those of you who weren’t able to register for this year's EduCon, there’s still time to sign up to access the 11 on-demand programs for CE credit. Click here to register and get started.

February 22, 2023

EduCon: It’s a wrap…or is it?

For those of you who weren’t able to register for EduCon last week, there’s still time to sign up to access the 11 on-demand programs for CE credit.

February 22, 2023

If you own or manage a compounding pharmacy, you cannot miss this conference

APC’s annual Owner Summit—March 26 to 28 at the Grand Hotel, Point Clear, Alabama—is THE conference that is 100 percent designed just for owners like you.

February 17, 2023

CVM responds to GFI 256 questions

FDA’s Center for Veterinary Medicine responded this week to a July 26, 2022, letter from APC and NCPA requesting answers to more than 30 technical questions about GFI 256 compliance. 

February 17, 2023

Announcing the 2023 PCF/PMIC Scholarship recipients!

Congratulations to the 2023 recipients of the Pharmacy Compounding Foundation and Pharmacists Mutual Compounding Scholarship.

February 17, 2023

Beset by business challenges? We’ve got the cure for what ails you.

For compounding pharmacy and facility owners, APC’s Owner Summit is the top learning, planning and idea-sharing event of the year—and it’s only five weeks away.

February 17, 2023

CC: February 17, 2023

Compounding Connections: February 17, 2023

February 15, 2023

Tomorrow is a big day for compounding. It’s when we’ll tell you our plans for helping you take back your profession.

Other voices have been telling the story of compounding—at FDA, in the halls of Congress, and in the media. To hear them tell it, you work in a dangerous, unregulated profession that puts patients at risk.

« Newer EntriesOlder Entries »